Ardent Health, Inc.

ARDT Healthcare Medical Care Facilities

Ardent Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.3 billion, up 6.01% from fiscal 2024. In the quarter to June 2026, revenue fell 1.40%, EPS fell 76.9%, free cash flow grew 121.7% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

11.95 0.25 −2.05%
Market cap
$1.7B
P/E
21.7×
Fwd P/E
7.7×
Dividend yield
—
F-score
6/9
Altman Z
1.97
Beneish M
−2.77
Dividend safety
n/a

Ardent Health, Inc. (ARDT) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Ardent Health, Inc. (ARDT) trades at a EV/Sales of 0.3×. Over the past ten years it has ranged from 0.2× (January 2026) to 0.6× (August 2024); the current reading is higher than 41% of that period. That is below the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 0.3× (45.01%)
FY2024 0.5× (4.61%)
FY2023 0.5× 0.00%
FY2022 0.5× 0.00%
FY2021 0.5× —

Quarterly newest first

Period EV/Sales Change
Jun 2026 0.3× 3.95%
Mar 2026 0.3× 3.06%
Dec 2025 0.3× (31.06%)
Sep 2025 0.4× (6.68%)
8 more quarters

Against its own ten years

Low 0.2× High 0.6×
Ten-year median 0.4×
Current reading's percentile 41

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ARDT